KelleyClarkO'DonnellMDPhD

Psychiatrist

Dr. O'Donnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am an Assistant Professor of Psychiatry at the NYU School of Medicine, and a board-certified psychiatrist practicing in New York City. At the NYU Psychedelic Medicine Research Program, my current focus is on clinical trials of psychedelic substances for the treatment of addiction, trauma, and mood disorders. I am particularly interested in the psychotherapy framework for psychedelic medicine, and in training the next generation of psychedelic therapists and facilitators.

PubMed

56 citations
Antidepressant-like responses to lithium in genetically diverse mouse strains.
Adem Can, Robert A. Blackwell, Sean C. Piantadosi, David T. Dao, Kelley C. O’Donnell
Genes, Brain, and Behavior. 2011-06-01
65 citations
Generation and Behavioral Characterization of β-catenin Forebrain-Specific Conditional Knock-Out Mice
Todd D. Gould, Kelley C. O’Donnell, Alyssa M. Picchini, Eliot R. Dow, Guang Chen
Behavioural Brain Research. 2008-05-16
88 citations
Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test.
Todd D. Gould, Kelley C. O’Donnell, Eliot R. Dow, Jing Du, Guang Chen
Neuropharmacology. 2008-03-01

Psychedelic Drug Therapy May Help Treat Alcohol AddictionAugust 24th, 2022
Psychedelic Drug MDMA Faces FDA Panel in Bid to Become First-of-a-kind PTSD MedicationJune 5th, 2024